Aspira Women's Health Inc... (AWH)
| Bid | n/a |
| Market Cap | 2.89M |
| Revenue (ttm) | 9.18M |
| Net Income (ttm) | -13.09M |
| EPS (ttm) | -0.93 |
| PE Ratio (ttm) | -0.09 |
| Forward PE | -0.32 |
| Analyst | Buy |
| Ask | n/a |
| Volume | 2,869,147 |
| Avg. Volume (20D) | 4,780,901 |
| Open | 0.09 |
| Previous Close | 0.08 |
| Day's Range | 0.08 - 0.09 |
| 52-Week Range | 0.02 - 3.45 |
| Beta | 2.01 |
About AWH
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service fo...
Analyst Forecast
According to 1 analyst ratings, the average rating for AWH stock is "Buy." The 12-month stock price forecast is $5.5, which is an increase of 6607.32% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago · accessnewswire.com
Aspira Women's Health Inc. to Begin Trading April 17th On OTC Under the Symbol "AWHL"SHELTON, CT / ACCESS Newswire / April 17, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gyneco...
2 weeks ago · accessnewswire.com
Aspira Women's Health Inc. Announces Receipt of Delisting Notification from NasdaqSHELTON, CT / ACCESS Newswire / April 16, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gyneco...
3 weeks ago · accessnewswire.com
Aspira Appoints Three New Directors, Executes $2.0 Million Equity Purchase AgreementNew Directors Bring Extensive Commercial Healthcare Relationships to Expand Business Development Opportunities. AUSTIN, TX / ACCESS Newswire / April 8, 2025 / Aspira Women's Health Inc. ("Aspira" o...
1 month ago · accessnewswire.com
Aspira Receives $1.5 million Milestone Payment from the ARPA-H Sprint for Women's Health AwardThe Company Successfully Reaches the Second Milestone of ARPA-H $10 Million Award AUSTIN, TX / ACCESS Newswire / March 31, 2025 / Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical...
1 month ago · accessnewswire.com
Aspira Women's Health Reports Fourth Quarter and Full Year 2024 Financial ResultsRecord 2024 OvaSuite revenue of $9.2 million and volume of 24,305 units sold AUSTIN, TX / ACCESS Newswire / March 27, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (Nasdaq:AWH), a bio-...
2 months ago · accessnewswire.com
Aspira Women's Health Announces Appointment of Ellen Beausang to the Board of DirectorsAUSTIN, TX / ACCESS Newswire / February 11, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gyne...